Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -28.60% is 25% above its 2-year average of -38.29%, near the high end of its 2-year range (-93.09%–-21.94%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.80% below its 12-month average of -28.10%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -28.60%.
RETURN ON INVESTED CAPITAL (ROIC)
-28.60%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-28.10%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-1.80%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 660 covered companies
CURRENT VS SECTOR MEDIAN
+14.91%
vs the sector median at left
MBX Biosciences, Inc. Common Stock
Market Cap
$2.75B
Return on Invested Capital (ROIC)
-28.60%
TTM Avg
-28.10%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.73B
Return on Invested Capital (ROIC)
-28.02%
TTM Avg
-99.23%
3Y Avg
-79.58%
5Y Avg
-63.04%
Market Cap
$2.79B
Return on Invested Capital (ROIC)
2.04%
TTM Avg
-4.01%
3Y Avg
-5.25%
5Y Avg
-2.96%
Market Cap
$2.70B
Return on Invested Capital (ROIC)
6.69%
TTM Avg
7.54%
3Y Avg
8.48%
5Y Avg
6.84%
Market Cap
$2.69B
Return on Invested Capital (ROIC)
15.45%
TTM Avg
14.86%
3Y Avg
6.92%
5Y Avg
-8.67%
Market Cap
$2.69B
Return on Invested Capital (ROIC)
-0.68%
TTM Avg
-0.20%
3Y Avg
0.55%
5Y Avg
2.38%
Market Cap
$2.82B
Return on Invested Capital (ROIC)
5.87%
TTM Avg
7.96%
3Y Avg
-0.22%
5Y Avg
-9.17%
Market Cap
$2.64B
Return on Invested Capital (ROIC)
-28.96%
TTM Avg
-36.25%
3Y Avg
-29.21%
5Y Avg
-30.95%
Market Cap
$2.64B
Return on Invested Capital (ROIC)
-38.70%
TTM Avg
-28.14%
3Y Avg
-29.66%
5Y Avg
-30.84%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MBX Biosciences, Inc. Common Stock (MBX) | $2.75B | -28.60% | -28.10% | N/A | N/A |
| Precigen, Inc. (PGEN)vs › | $2.73B | -28.02% | -99.23% | -79.58% | -63.04% |
| AtriCure, Inc. (ATRC)vs › | $2.79B | 2.04% | -4.01% | -5.25% | -2.96% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.70B | 6.69% | 7.54% | 8.48% | 6.84% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 15.45% | 14.86% | 6.92% | -8.67% |
| Neogen Corporation (NEOG)vs › | $2.69B | -0.68% | -0.20% | 0.55% | 2.38% |
| TransMedics Group, Inc. (TMDX)vs › | $2.82B | 5.87% | 7.96% | -0.22% | -9.17% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | -28.96% | -36.25% | -29.21% | -30.95% |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.64B | -38.70% | -28.14% | -29.66% | -30.84% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.89B | -58.28% | -46.81% | -91.88% | -70.41% |
ROIC
-28.6%
ROE
-25.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -28.60% |
| 2026-03-31 | -22.55% |
| 2025-12-31 | -26.53% |
| 2025-09-30 | -23.42% |
| 2025-06-30 | -39.39% |
| 2025-03-31 | -34.58% |
| 2024-12-31 | -26.48% |
| 2024-09-30 | -21.94% |
| 2024-06-30 | -93.09% |
| 2024-03-31 | -60.56% |
| 2023-12-31 | -44.00% |
